Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Progression-free Survival
100%
Negative Predictive Value
100%
18F-FDG PET-CT
100%
Cancer Patients
100%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Locally Advanced
100%
CT Prediction
100%
Treatment Outcome Prediction
100%
Human Papillomavirus
100%
Locoregional Control
80%
Positron Emission Tomography/computed Tomography (PET/CT)
80%
PET Scan
40%
Reduced Dose
40%
P16-positive
40%
Overall Scores
40%
Locoregionally Advanced
40%
Lower Confidence Bound
40%
Intensity-modulated Radiotherapy
20%
Median Time
20%
Cancer Stage
20%
Phase II Trial
20%
Chemoradiation
20%
Residual Tumor
20%
Pack-years
20%
Cisplatin
20%
End of Treatment
20%
Tumor Response Evaluation
20%
Ordinal Scale
20%
Dose Intensity
20%
CT Analysis
20%
Hopkins Statistic
20%
Locoregional Control Rate
20%
Lack of Evidence
20%
De-intensification
20%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Fluorodeoxyglucose F 18
100%
Wart Virus
100%
Oropharynx Carcinoma
100%
Treatment Outcome
100%
Progression Free Survival
71%
Neoplasm
28%
Neck
28%
P16
28%
X-Ray Computed Tomography
28%
Intensity Modulated Radiation Therapy
14%
Cisplatin
14%
Chemoradiotherapy
14%
Subgroup Analysis
14%
Phase II Trials
14%
Cancer Stages
14%
Nursing and Health Professions
Positron Emission Tomography-Computed Tomography
100%
Treatment Outcome
100%
Fluorodeoxyglucose F 18
100%
Oropharynx Cancer
100%
Oropharynx Carcinoma
100%
Predictive Value
71%
Progression Free Survival
71%
Neoplasm
28%
X-Ray Computed Tomography
28%
Chemoradiotherapy
14%
Radiation Dose
14%
Intensity Modulated Radiation Therapy
14%
Cisplatin
14%
Immunology and Microbiology
Wart Virus
100%
Positron Emission Tomography-Computed Tomography
100%
Progression Free Survival
71%
Neck
28%
X-Ray Computed Tomography
28%
Cancer Staging
14%